DE | Accessible presentation
Translations are powered by AI

How Munich biotech startups are fighting cancer

Munich is one of Germany's leading biotech hubs. Research is being conducted here on a wide variety of drugs and therapies, including cancer treatments. We'll introduce you to five startups in more detail.

February 21, 2023 4 min reading time

Adrian Schomburg, CEO at Eisbach Bio
Eisbach Organic focuses on certain types of cancer in which defective cell division mechanisms lead to constant changes in the tumor genome. This makes these types of cancer particularly difficult to combat. The startup is now attacking the internal mechanisms of cancer cells by interfering with their processes using specific molecules. This ultimately blocks the tumor's disease-relevant functions. The startup, founded by Adrian Schomburg (pictured) and Andreas Ladurner, is also developing a SARS-CoV-19 drug that uses similar mechanisms. For this, the startup received funding of over €8 million from the Federal Ministry of Education and Research in 2021, as well as a further €6.7 million from the Bavarian State Government. (Image: Eisbach Bio)
read more ↓